Maduramicin antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Maduramicin antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Antibiotics diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-40-1 | 1. BSA-Maduramicin 2. Anti-Maduramicin mouse monoclonal antibody | $2709.00 |
GMP-SMT-40-2 | 1. OVA-Maduramicin 2. Anti-Maduramicin mouse monoclonal antibody | $2709.00 |
GMP-SMT-40-3 | 1. BSA-Maduramicin 2. Anti-Maduramicin human monoclonal antibody | $2709.00 |
GMP-SMT-40-4 | 1. OVA-Maduramicin 2. Anti-Maduramicin human monoclonal antibody | $2709.00 |
GMP-SMT-40-Ag-1 | BSA-Maduramicin | $756.00 |
GMP-SMT-40-Ag-2 | OVA-Maduramicin | $756.00 |
GMP-SMT-40-Ab-1 | Anti-Maduramicin mouse monoclonal antibody | $1953.00 |
GMP-SMT-40-Ab-2 | Anti-Maduramicin human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Maduramicin
Cat No. | GMP-SMT-40-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Maduramicin with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Maduramicin had been validated with our anti-Hapten antibody Anti-Maduramicin mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Maduramicin
Cat No. | GMP-SMT-40-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Maduramicin with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Maduramicin had been validated with our anti-Hapten antibody Anti-Maduramicin mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Maduramicin mouse monoclonal antibody
Cat No. | GMP-SMT-40-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.4-0.5 |
Products description | The anti-Hapten antibody against hapten Maduramicin had been validated with our hapten hapten-carrier conjugates BSA-Maduramicin via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Maduramicin human monoclonal antibody
Cat No. | GMP-SMT-40-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.4-0.5 |
Products description | The anti-Hapten antibody against hapten Maduramicin had been validated with our hapten hapten-carrier conjugates BSA-Maduramicin via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Biomarker Information
1. Maduramicin in Veterinary Drug Residues and Additives:
Maduramicin, an ionophore antibiotic (Serial Number 1), holds a prominent place in the realm of veterinary medicine, specifically as a crucial additive in animal feed. This small molecule is widely employed in the husbandry of poultry and livestock. Its significance in veterinary drug residues and additives cannot be overstated.
Role in Coccidiosis Control (Serial Number 2): Coccidiosis, a parasitic disease affecting poultry and livestock, presents a significant challenge to the agriculture industry. Maduramicin plays a pivotal role in addressing this issue. It effectively prevents and controls coccidiosis, thereby reducing the economic impact of this parasitic affliction. Coccidiosis can lead to considerable economic losses, ranging from reduced productivity to increased veterinary expenses. Maduramicin mitigates these losses by controlling the disease's spread.
Enhanced Feed Efficiency (Serial Number 3): Maduramicin's usage in animal feed is driven by its remarkable ability to enhance feed conversion efficiency. This ionophore antibiotic promotes weight gain and significantly improves nutrient utilization. As a result, it offers a compelling choice for farmers and producers aiming to optimize the growth and development of their livestock.
Reduction in Mortality (Serial Number 4): Maduramicin is instrumental in reducing mortality rates among poultry and livestock. The effective control of coccidiosis and the overall health benefits it bestows result in a notable reduction in mortality. This not only ensures the well-being of animals but also contributes to maintaining a sustainable and stable food supply.
Economic Benefits (Serial Number 5): Beyond its role in animal health, Maduramicin brings about economic advantages within the livestock industry. It enhances productivity by promoting healthier and more efficient growth. The reduced veterinary costs and minimized losses due to diseases directly contribute to the economic prosperity of the agricultural sector.
Regulatory Compliance (Serial Number 6): The use of Maduramicin in animal husbandry is subject to stringent regulatory guidelines and standards. Therefore, it is imperative to monitor and measure Maduramicin levels in animal products to ensure compliance with these regulations. This guarantees the safety of both consumers and the environment by preventing excessive residues that could be harmful.
2. The Significance of Measuring Maduramicin:
Measuring Maduramicin levels is a fundamental practice with a range of crucial implications (Serial Number 7):
Consumer Safety (Serial Number 8): Rigorous monitoring of Maduramicin is essential to guarantee the safety of animal products meant for human consumption. Maduramicin residues, if present in excess, can pose health risks to consumers. Ensuring that these residues remain within safe limits is a paramount consideration.
Regulatory Compliance (Serial Number 9): In the fields of pharmaceuticals and agriculture, adherence to regulatory guidelines is a non-negotiable requirement. Measuring Maduramicin content is a means to demonstrate unwavering adherence to regulations governing the use of veterinary drugs. It helps companies and producers avoid potential legal and reputational pitfalls.
Quality Assurance (Serial Number 10): Consistent and accurate measurements of Maduramicin levels in animal feed and products are instrumental in maintaining the quality and safety of these products. This is vital for building trust with consumers and stakeholders. It ensures that the products meet the highest standards and are free from any harmful residues.
Efficacy Evaluation (Serial Number 11): Measuring Maduramicin levels also serves as a tool for evaluating the effectiveness of its use in animal feed. It ensures that the drug is achieving its intended purposes, such as controlling coccidiosis and enhancing feed efficiency. Regular assessments provide insights into the product's performance, allowing for adjustments if needed.
Environmental Impact Mitigation (Serial Number 12): Beyond consumer safety and product quality, monitoring Maduramicin levels also has a significant environmental dimension. Preventing the excessive release of Maduramicin into ecosystems is vital to reduce its potential environmental impact. This contributes to the broader goal of sustainable and responsible agriculture.
In the realm of analytical testing and research, our biopharmaceutical company stands as a trusted partner, providing a comprehensive array of specialized reagents for the accurate and reliable measurement of Maduramicin levels. Our product offerings include anti-Maduramicin antibodies and small molecules competitive antigens, such as Carrier-coupled antigens, immunogens, hapten-carrier conjugates, BSA-conjugated, and OVA-conjugated reagents. These advanced tools empower researchers, regulators, and industry professionals to conduct precise and comprehensive assessments of Maduramicin in the context of veterinary drug residues and additives, ensuring the safety, efficacy, and sustainability of this essential component of modern animal agriculture.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.